Acute vs. chronic EEG effects in maprotiline- and in clomipramine-treated depressive inpatients and the prediction of therapeutic outcome
Patients treated with the norepinephrine uptake inhibitor maprotiline showed an opposite tendency between acute and chronic effect of EEG. Whereas the acute effect indicated a decrease upon EEG vigilance, the chronic effect indicated an increase. Under clomipramine which acts upon different transmit...
Gespeichert in:
Veröffentlicht in: | Journal of affective disorders 1994-11, Vol.32 (3), p.213-217 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 217 |
---|---|
container_issue | 3 |
container_start_page | 213 |
container_title | Journal of affective disorders |
container_volume | 32 |
creator | Ulrich, G. Haug, H.-J. Fähndrich, E. |
description | Patients treated with the norepinephrine uptake inhibitor maprotiline showed an opposite tendency between acute and chronic effect of EEG. Whereas the acute effect indicated a decrease upon EEG vigilance, the chronic effect indicated an increase. Under clomipramine which acts upon different transmitter systems in a complex, up to now not fully understood way, acute and chronic EEG effects could not be differentiated. |
doi_str_mv | 10.1016/0165-0327(94)90020-5 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_77751442</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0165032794900205</els_id><sourcerecordid>77751442</sourcerecordid><originalsourceid>FETCH-LOGICAL-c301t-ab9e9ee476c2d0fd42bab998b264637e17ce135a17a297c9b042a68123da32983</originalsourceid><addsrcrecordid>eNp9kc9qFTEUxoMo9Vp9A4UspOhiav5NMtkIpVyrUOimrkMmOUMjM5MxyVzwEXxrM72Xu3QRAt_5ne8k30HoPSXXlFD5pZ62IZypT1p81oQw0rQv0I62ijespeol2p2R1-hNzr8IIVIrcoEuVNcyKfkO_b1xawF8yNfYPaU4B4f3-zsMwwCuZBxmPNklxRLGMEOD7ew3zY1xCkuy0yaWBLaAxx6WBDmHA1RksSXAXB22jvIEuNZ8cCXEGcdhU5JdYC11XlyLixO8Ra8GO2Z4d7ov0c9v-8fb7839w92P25v7xnFCS2N7DRpAKOmYJ4MXrK-S7nomheQKqHJAeWupskwrp3simJUdZdxbznTHL9HV0bd-6_cKuZgpZAfjaGeIazZKqZYKwSoojqBLMecEg1lSmGz6Yygx2wbMFq_Z4jVamOcNmLa2fTj5r_0E_tx0irzWP57qNjs7DsnOLuQzxqtdJ0XFvh4xqFkcAiSTXU3U1RRTXY3xMfz_Hf8AzmyjnQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>77751442</pqid></control><display><type>article</type><title>Acute vs. chronic EEG effects in maprotiline- and in clomipramine-treated depressive inpatients and the prediction of therapeutic outcome</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Ulrich, G. ; Haug, H.-J. ; Fähndrich, E.</creator><creatorcontrib>Ulrich, G. ; Haug, H.-J. ; Fähndrich, E.</creatorcontrib><description>Patients treated with the norepinephrine uptake inhibitor maprotiline showed an opposite tendency between acute and chronic effect of EEG. Whereas the acute effect indicated a decrease upon EEG vigilance, the chronic effect indicated an increase. Under clomipramine which acts upon different transmitter systems in a complex, up to now not fully understood way, acute and chronic EEG effects could not be differentiated.</description><identifier>ISSN: 0165-0327</identifier><identifier>EISSN: 1573-2517</identifier><identifier>DOI: 10.1016/0165-0327(94)90020-5</identifier><identifier>PMID: 7852663</identifier><identifier>CODEN: JADID7</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Acute vs. chronic effects ; Adult ; Aged ; Antidepressive drug ; Biological and medical sciences ; Clomipramine - administration & dosage ; Clomipramine - pharmacology ; Clomipramine - therapeutic use ; Depressive Disorder - diagnosis ; Depressive Disorder - drug therapy ; Dose-Response Relationship, Drug ; EEG vigilance ; Electroencephalography - drug effects ; Female ; Humans ; Male ; Maprotiline - administration & dosage ; Maprotiline - pharmacology ; Maprotiline - therapeutic use ; Medical sciences ; Middle Aged ; Neuropharmacology ; Pharmacology. Drug treatments ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopharmacology ; Test-dose model ; Treatment Outcome</subject><ispartof>Journal of affective disorders, 1994-11, Vol.32 (3), p.213-217</ispartof><rights>1994</rights><rights>1995 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c301t-ab9e9ee476c2d0fd42bab998b264637e17ce135a17a297c9b042a68123da32983</citedby><cites>FETCH-LOGICAL-c301t-ab9e9ee476c2d0fd42bab998b264637e17ce135a17a297c9b042a68123da32983</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0165-0327(94)90020-5$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3327864$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7852663$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ulrich, G.</creatorcontrib><creatorcontrib>Haug, H.-J.</creatorcontrib><creatorcontrib>Fähndrich, E.</creatorcontrib><title>Acute vs. chronic EEG effects in maprotiline- and in clomipramine-treated depressive inpatients and the prediction of therapeutic outcome</title><title>Journal of affective disorders</title><addtitle>J Affect Disord</addtitle><description>Patients treated with the norepinephrine uptake inhibitor maprotiline showed an opposite tendency between acute and chronic effect of EEG. Whereas the acute effect indicated a decrease upon EEG vigilance, the chronic effect indicated an increase. Under clomipramine which acts upon different transmitter systems in a complex, up to now not fully understood way, acute and chronic EEG effects could not be differentiated.</description><subject>Acute vs. chronic effects</subject><subject>Adult</subject><subject>Aged</subject><subject>Antidepressive drug</subject><subject>Biological and medical sciences</subject><subject>Clomipramine - administration & dosage</subject><subject>Clomipramine - pharmacology</subject><subject>Clomipramine - therapeutic use</subject><subject>Depressive Disorder - diagnosis</subject><subject>Depressive Disorder - drug therapy</subject><subject>Dose-Response Relationship, Drug</subject><subject>EEG vigilance</subject><subject>Electroencephalography - drug effects</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Maprotiline - administration & dosage</subject><subject>Maprotiline - pharmacology</subject><subject>Maprotiline - therapeutic use</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Test-dose model</subject><subject>Treatment Outcome</subject><issn>0165-0327</issn><issn>1573-2517</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc9qFTEUxoMo9Vp9A4UspOhiav5NMtkIpVyrUOimrkMmOUMjM5MxyVzwEXxrM72Xu3QRAt_5ne8k30HoPSXXlFD5pZ62IZypT1p81oQw0rQv0I62ijespeol2p2R1-hNzr8IIVIrcoEuVNcyKfkO_b1xawF8yNfYPaU4B4f3-zsMwwCuZBxmPNklxRLGMEOD7ew3zY1xCkuy0yaWBLaAxx6WBDmHA1RksSXAXB22jvIEuNZ8cCXEGcdhU5JdYC11XlyLixO8Ra8GO2Z4d7ov0c9v-8fb7839w92P25v7xnFCS2N7DRpAKOmYJ4MXrK-S7nomheQKqHJAeWupskwrp3simJUdZdxbznTHL9HV0bd-6_cKuZgpZAfjaGeIazZKqZYKwSoojqBLMecEg1lSmGz6Yygx2wbMFq_Z4jVamOcNmLa2fTj5r_0E_tx0irzWP57qNjs7DsnOLuQzxqtdJ0XFvh4xqFkcAiSTXU3U1RRTXY3xMfz_Hf8AzmyjnQ</recordid><startdate>199411</startdate><enddate>199411</enddate><creator>Ulrich, G.</creator><creator>Haug, H.-J.</creator><creator>Fähndrich, E.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>199411</creationdate><title>Acute vs. chronic EEG effects in maprotiline- and in clomipramine-treated depressive inpatients and the prediction of therapeutic outcome</title><author>Ulrich, G. ; Haug, H.-J. ; Fähndrich, E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c301t-ab9e9ee476c2d0fd42bab998b264637e17ce135a17a297c9b042a68123da32983</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Acute vs. chronic effects</topic><topic>Adult</topic><topic>Aged</topic><topic>Antidepressive drug</topic><topic>Biological and medical sciences</topic><topic>Clomipramine - administration & dosage</topic><topic>Clomipramine - pharmacology</topic><topic>Clomipramine - therapeutic use</topic><topic>Depressive Disorder - diagnosis</topic><topic>Depressive Disorder - drug therapy</topic><topic>Dose-Response Relationship, Drug</topic><topic>EEG vigilance</topic><topic>Electroencephalography - drug effects</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Maprotiline - administration & dosage</topic><topic>Maprotiline - pharmacology</topic><topic>Maprotiline - therapeutic use</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Test-dose model</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ulrich, G.</creatorcontrib><creatorcontrib>Haug, H.-J.</creatorcontrib><creatorcontrib>Fähndrich, E.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of affective disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ulrich, G.</au><au>Haug, H.-J.</au><au>Fähndrich, E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acute vs. chronic EEG effects in maprotiline- and in clomipramine-treated depressive inpatients and the prediction of therapeutic outcome</atitle><jtitle>Journal of affective disorders</jtitle><addtitle>J Affect Disord</addtitle><date>1994-11</date><risdate>1994</risdate><volume>32</volume><issue>3</issue><spage>213</spage><epage>217</epage><pages>213-217</pages><issn>0165-0327</issn><eissn>1573-2517</eissn><coden>JADID7</coden><abstract>Patients treated with the norepinephrine uptake inhibitor maprotiline showed an opposite tendency between acute and chronic effect of EEG. Whereas the acute effect indicated a decrease upon EEG vigilance, the chronic effect indicated an increase. Under clomipramine which acts upon different transmitter systems in a complex, up to now not fully understood way, acute and chronic EEG effects could not be differentiated.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>7852663</pmid><doi>10.1016/0165-0327(94)90020-5</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0165-0327 |
ispartof | Journal of affective disorders, 1994-11, Vol.32 (3), p.213-217 |
issn | 0165-0327 1573-2517 |
language | eng |
recordid | cdi_proquest_miscellaneous_77751442 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Acute vs. chronic effects Adult Aged Antidepressive drug Biological and medical sciences Clomipramine - administration & dosage Clomipramine - pharmacology Clomipramine - therapeutic use Depressive Disorder - diagnosis Depressive Disorder - drug therapy Dose-Response Relationship, Drug EEG vigilance Electroencephalography - drug effects Female Humans Male Maprotiline - administration & dosage Maprotiline - pharmacology Maprotiline - therapeutic use Medical sciences Middle Aged Neuropharmacology Pharmacology. Drug treatments Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopharmacology Test-dose model Treatment Outcome |
title | Acute vs. chronic EEG effects in maprotiline- and in clomipramine-treated depressive inpatients and the prediction of therapeutic outcome |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T07%3A31%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acute%20vs.%20chronic%20EEG%20effects%20in%20maprotiline-%20and%20in%20clomipramine-treated%20depressive%20inpatients%20and%20the%20prediction%20of%20therapeutic%20outcome&rft.jtitle=Journal%20of%20affective%20disorders&rft.au=Ulrich,%20G.&rft.date=1994-11&rft.volume=32&rft.issue=3&rft.spage=213&rft.epage=217&rft.pages=213-217&rft.issn=0165-0327&rft.eissn=1573-2517&rft.coden=JADID7&rft_id=info:doi/10.1016/0165-0327(94)90020-5&rft_dat=%3Cproquest_cross%3E77751442%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=77751442&rft_id=info:pmid/7852663&rft_els_id=0165032794900205&rfr_iscdi=true |